A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.
about
In vivo imaging of therapy-induced anti-cancer immune responses in humans.TYR as a multifunctional reporter gene regulated by the Tet-on system for multimodality imaging: an in vitro studyStructure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe.Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes.Cell fate control gene therapy based on engineered variants of human deoxycytidine kinaseA Positive Selection for Nucleoside Kinases in E. coliLong-term in vivo monitoring of mouse and human hematopoietic stem cell engraftment with a human positron emission tomography reporter gene.Mesothelin-targeted immunotherapies for malignant pleural mesothelioma.Application of a rapid, simple, and accurate adenovirus-based method to compare PET reporter gene/PET reporter probe systems.Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunityComparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging.Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications.Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.Advances in PET Detection of the Antitumor T Cell Response.Advancing Immune and Cell-Based Therapies Through Imaging.Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer.Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage.Evaluation of prostate-specific membrane antigen as an imaging reporter.Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma.Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy.Multimodality reporter gene imaging: Construction strategies and application.
P2860
Q27693338-70916153-5A22-4149-A0C5-A4D381D26B4EQ30399658-7CE08542-43C0-4305-A3BD-E6CB33DE0F3AQ35643725-4151F6BF-04EA-44AC-AD3B-3B738FC49E3CQ35719906-5BC4B9EE-53A9-4D07-A850-79061CF21121Q35880086-B8A2F471-D557-4960-B39B-A71E3979E8BCQ35939470-C45D5E6D-2E81-4979-AA01-6AF052B4A650Q36146148-9B79C72D-8644-43E7-90CD-8B45976F933CQ36583196-AEE2AD89-89A0-499C-B4E4-C827DC79FB1AQ37090793-5A9D7D8F-A56C-4266-AE88-60E9E6F5B619Q37323681-E53D5C92-577C-40C9-8119-E889F50AC11CQ37469199-AD583EB1-9435-4B4D-8705-2681A694A0E1Q37693526-BE13EBC4-77E7-49BF-8584-8856FF7F54A2Q38003153-C87B4B2D-49DB-4997-BD9E-30986C945E86Q38738879-6518325C-867A-4AE5-A5C4-2BC0F18D9C26Q38846891-4A7155E7-8BA5-4AAF-993E-68A22AAC7668Q39167485-4BF365E2-1FB9-433D-A5D6-468233EEC436Q39386066-03883097-8EEB-4DEA-8777-F46B267A115EQ40262447-C0FF3BE7-2A35-43BA-B50A-25B3808018D1Q41462083-28A42E65-0F8B-4DFD-9E11-02EDD5D0B2D8Q41573147-F4C6A17A-6477-45C9-A64E-08A8AD39724FQ48556437-57A9ABEE-1621-487C-A745-B85810A5999AQ55046163-D81508DB-5024-41C5-B6E0-DFABFAB9FEE3
P2860
A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A new pyrimidine-specific repo ...... anosine-based cytotoxic drugs.
@en
A new pyrimidine-specific repo ...... anosine-based cytotoxic drugs.
@nl
type
label
A new pyrimidine-specific repo ...... anosine-based cytotoxic drugs.
@en
A new pyrimidine-specific repo ...... anosine-based cytotoxic drugs.
@nl
prefLabel
A new pyrimidine-specific repo ...... anosine-based cytotoxic drugs.
@en
A new pyrimidine-specific repo ...... anosine-based cytotoxic drugs.
@nl
P2093
P2860
P1476
A new pyrimidine-specific repo ...... anosine-based cytotoxic drugs.
@en
P2093
Anton Neschadim
Jeffrey A Medin
Juan Zurita
Konstantin Dobrenkov
Larissa Shenker
Michel Sadelain
Shangde Cai
Vladimir Ponomarev
Yury Likar
P2860
P304
P356
10.2967/JNUMED.109.074344
P407
P577
2010-09-01T00:00:00Z